Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 62
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Affective valence predictors from real-world based short sprint interval training

  • Benitez-Flores, Stefano
  • de Souza Castro, Flávio Antônio
  • Caldas Costa, Eduardo
  • Boullosa Álvarez, Daniel Alexandre
  • Astorino, Todd Anthony
[EN] Affective valence is typically positive at exercise intensities below the lactate threshold, yet more aversive responses occur at supra-threshold intensities. Nevertheless, the physiological and psychological predictors of affective valence during supramaximal intensities including short sprint interval training (sSIT) have not yet been elucidated. Seventeen (7 women/10 men) moderately active young adults (age ​= ​[28.2 ​± ​5.6] years; V˙O2max [maximum oxygen consumption] ​= ​[52.9 ​± ​8.1] mL·kg−1·min−1; BMI [body mass index] ​= ​[24 ​± ​2] kg·m−2) completed four low-volume running sSIT sessions (10 ​× ​4 ​s efforts with 30 ​s of passive recovery). We recorded participants’ heart rate (HR), root mean square of successive differences of normal RR intervals (RMSSD), heart rate recovery (HRR), ratings of perceived exertion (RPE), feeling scale (FS), intention and self-efficacy during, and after each session. Overall, no significant correlation (p ​> ​0.05) was found between FS and baseline clinical outcomes. No significant correlation (p ​> ​0.05) was detected between FS and any training parameter. No significant correlations were noted between FS and exercise task self-efficacy and intentions (p ​> ​0.05). The regression model was significant (F3,61 ​= ​5.57; p ​= ​0.002) and only three variables significantly entered the generated model: ΔHRRend-120s end (p ​= ​0.002; VIF ​= ​2.58; 40.8%), time ≥ 90% HRpeak (p ​= ​0.001; VIF ​= ​1.26; 31.6%), and RMSSDend (p ​= ​0.025; VIF ​= ​2.23; 27.6%). These findings suggest that HR-based measures, particularly those related to in-task stress (time ≥ 90% HRpeak) and acute recovery (ΔHRRend-120s end, and RMSSDend), may predict affective valence during real-world sSIT., SI, European Union Next Generation EU, Conselho Nacional de Desenvolvimento Científico e Tecnológico Brazil, Comisión Sectorial de Investigación Científica Uruguay, PRTR
Docta Complutense
Publicación Artículo científico (JournalArticle)

Clinical, cognitive, and neuroimaging evidence of a neurodevelopmental continuum in offspring of probands with schizophrenia and bipolar disorder

  • Sugranyes, Gisela
  • Serna, Elena de la
  • Borras, Roger
  • Sanchez Gistau, Vanessa
  • Pariente, Jose C.
  • Romero, Soledad
  • Baeza, Inmaculada
  • Martínez Díaz-Caneja, María Covadonga
  • Rodríguez Toscano, Elisa
  • Moreno Ruiz, María del Carmen
  • Bernardo, Miguel
  • Moreno Pardillo, Dolores María
  • Vieta, Eduard
  • Castro Fornieles, Josefina
Background: Studies in child and adolescent offspring of patients with schizophrenia or bipolar disorders may help understand the influence of neurodevelopmental factors on the premorbid phenotype of these disorders. Aims: To assess whether a combination of neurodevelopmental factors discriminates between young offspring of patients with schizophrenia (SzO) or bipolar disorder (BpO) and community controls (CcO). To assess the association between these factors and rates of psychiatric diagnoses in high risk (HR) youth. Methods: One hundred thirty-three HR offspring (47 SzO and 86 BpO) and 84 CcO, aged 6–17, underwent cross-sectional clinical, neurocognitive, and structural neuroimaging assessment. Information on perinatal events and early childhood development was also obtained. General linear mixed models were performed to assess group discrimination and association with lifetime axis I psychiatric disorders. Results: Multivariate analyses revealed that greater neurological soft signs (NSS), less total grey matter volume (GMV) and a higher frequency of obstetric complications discriminated HR offspring from CcO. When comparing each group individually, greater NSS and a higher frequency of obstetric complications discriminated SzO from CcO, and BpO from CcO, while lower intelligence also discriminated SzO from CcO and from BpO. Within HR offspring, lower intelligence and less total GMV were associated with lifetime incidence of psychiatric disorders. Conclusions: Both SzO and BpO showed evidence of neurodevelopmental insult, although this may have a greater impact in SzO. Lower intelligence and less total GMV hold potential as biomarkers of risk for psychiatric disorders in HR youth.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Assessment of school anti-bullying interventions: A Meta-analysis of randomized clinical trials

  • Fraguas Herráez, David
  • Díaz Caneja, Covadonga M.
  • Ayora, Miriam
  • Durán Cutilla, Manuel
  • Abregú Crespo, Renzo
  • Ezquiaga Bravo, Iciar
  • Martín Babarro, Javier
  • Arango López, Celso
Importance: Bullying is a prevalent and modifiable risk factor for mental health disorders. Although previous studies have supported the effectiveness of anti-bullying programs; their population impact and the association of specific moderators with outcomes are still unclear. Objective: To assess the effectiveness of school anti-bullying interventions, their population impact, and the association between moderator variables and outcomes. Data Sources: A search of Ovid MEDLINE, ERIC, and PsycInfo databases was conducted using 3 sets of search terms to identify randomized clinical trials (RCTs) assessing anti-bullying interventions published from database inception through February 2020. A manual search of reference lists of articles included in previous systematic reviews and meta-analyses was also performed. Study Selection: The initial literature search yielded 34 798 studies. Included in the study were articles that (1) assessed bullying at school; (2) assessed the effectiveness of an anti-bullying program; (3) had an RCT design; (4) reported results; and (5) were published in English. Of 16 707 studies identified, 371 met the criteria for review of full-text articles; 77 RCTs were identified that reported data allowing calculation of effect sizes (ESs). Of these, 69 independent trials were included in the final meta-analysis database. Data Extraction and Synthesis: Random-effects and meta-regression models were used to derive Cohen d values with pooled 95% CIs as estimates of ES and to test associations between moderator variables and ES estimates. Population impact number (PIN), defined as the number of children in the total population for whom 1 event may be prevented by an intervention, was used as an estimate of the population impact of universal interventions targeting all students, regardless of individual risk. Main Outcomes and Measures: The main outcomes are the effectiveness (measured by ES) and the population impact (measured by the PIN) of anti-bullying interventions on the following 8 variable categories: Overall bullying, bullying perpetration, bullying exposure, cyberbullying, attitudes that discourage bullying, attitudes that encourage bullying, mental health problems (eg, anxiety and depression), and school climate as well as the assessment of potential assocations between trial or intervention characteristics and outcomes. Results: This study included 77 samples from 69 RCTs (111659 participants [56511 in the intervention group and 55148 in the control group]). The weighted mean (range) age of participants in the intervention group was 11.1 (4-17) years and 10.8 (4-17) years in the control group. The weighted mean (range) proportion of female participants in the intervention group was 49.9% (0%-100%) and 50.5% (0%-100%) in the control group. Anti-bullying interventions were efficacious in reducing bullying (ES,-0.150; 95% CI,-0.191 to-0.109) and improving mental health problems (ES,-0.205; 95% CI,-0.277 to-0.133) at study end point, with PINs for universal interventions that target the total student population of 147 (95% CI, 113-213) and 107 (95% CI, 73-173), respectively. Duration of intervention was not statistically significantly associated with intervention effectiveness (mean [range] duration of interventions, 29.4 [1 to 144] weeks). The effectiveness of anti-bullying programs did not diminish over time during follow-up (mean [range] follow-up, 30.9 [2-104] weeks). Conclusions and Relevance: Despite the small ESs and some regional differences in effectiveness, the population impact of school anti-bullying interventions appeared to be substantial. Better designed trials that assess optimal intervention timing and duration are warranted.
Repisalud
Publicación Artículo científico (JournalArticle)

Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases.

  • Devesa, Ana
  • Delgado, Victoria
  • Valkovic, Ladislav
  • Lima, Joao A C
  • Nagel, Eike
  • Ibanez, Borja
  • Raman, Betty
Cardiometabolic diseases encompass a group of conditions characterized by metabolic and inflammatory abnormalities that increase the risk of diabetes and cardiovascular disease. These syndromes involve multiple organs, including the heart, arterial system, brain, skeletal muscle, adipose tissue, hematopoietic system, liver, kidneys, and pancreas. The crosstalk between these organs contributes to the development of disease. Advances in imaging techniques, such as magnetic resonance imaging, magnetic resonance spectroscopy, computed tomography, and positron emission tomography, have revolutionized the evaluation of these conditions. Hybrid imaging modalities, such as positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging, provide unique insights into the anatomy and metabolic alterations occurring in response to cardiometabolic risk factors. These methods are particularly valuable for assessing multisystemic involvement and interorgan crosstalk, revealing critical interactions such as the brain-heart axis, the heart-liver axis, and the fat-muscle-heart dynamics. This review discusses the role of state-of-the-art imaging techniques in evaluating the pathophysiological mechanisms underlying these complex syndromes and the clinical applications of the different imaging techniques in the assessment of cardiometabolic diseases.
Repisalud
Publicación Artículo científico (JournalArticle)

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality.

  • Fuster, Valentin
  • García-Álvarez, Ana
  • Devesa, Ana
  • Mass, Virginia
  • Owen, Ruth
  • Quesada, Antonio
  • Fuster, José J
  • García-Lunar, Inés
  • Pocock, Stuart
  • Sánchez-González, Javier
  • Sartori, Samantha
  • Peyra, Carlos
  • Andres, Vicente
  • Muntendam, Pieter
  • Ibanez, Borja
Atherosclerosis is a dynamic process. There is little evidence regarding whether quantification of atherosclerosis extent and progression, particularly in the carotid artery, in asymptomatic individuals predicts all-cause mortality. This study sought to evaluate the independent predictive value (beyond cardiovascular risk factors) of subclinical atherosclerosis burden and progression and all-cause mortality. A population of 5,716 asymptomatic U.S. adults (mean age 68.9 years, 56.7% female) enrolled between 2008 and 2009 in the BioImage (A Clinical Study of Burden of Atherosclerotic Disease in an At Risk Population) study underwent examination by vascular ultrasound to quantify carotid plaque burden (cPB) (the sum of right and left carotid plaque areas) and by computed tomography for coronary artery calcium (CAC). Follow-up carotid vascular ultrasound was performed on 732 participants a median of 8.9 years after the baseline exam. All participants were followed up for all-cause mortality, the primary outcome. Trend HRs are the per-tertile increase in each variable. Over a median 12.4 years' follow-up, 901 (16%) participants died. After adjustment for cardiovascular risk factors and background medication, baseline cPB and CAC score were both significantly associated with all-cause mortality (fully adjusted trend HR: 1.23; 95% CI: 1.16-1.32; and HR: 1.15; 95% CI: 1.08-1.23), respectively (both P < 0.001), thus providing additional prognostic value. cPB performed better than CAC score. In participants with a second vascular ultrasound evaluation, median cPB progressed from 29.2 to 91.3 mm. cPB progression was significantly associated with all-cause mortality after adjusting for cardiovascular risk factors and baseline cPB (HR: 1.03; 95% CI: 1.01-1.04 per absolute 10-mm change; P = 0.01). Subclinical atherosclerosis burden (cPB and CAC) in asymptomatic individuals was independently associated with all-cause mortality. Moreover, atherosclerosis progression was independently associated with all-cause mortality.
Repisalud
Publicación Artículo científico (JournalArticle)

Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors.

  • Devesa, Ana
  • Fuster, Valentin
  • García-Lunar, Inés
  • Oliva, Belén
  • García-Alvarez, Ana
  • Moreno-Arciniegas, Andrea
  • Vazirani, Ravi
  • Pérez-Herreras, Cristina
  • Marina, Pablo
  • Bueno, Héctor
  • Fernández-Friera, Leticia
  • Fernández-Ortiz, Antonio
  • Sanchez-Gonzalez, Javier
  • Ibanez, Borja
  • Devesa, Ana
  • Fuster, Valentin
  • García-Lunar, Inés
  • Oliva, Belén
  • García-Alvarez, Ana
  • Moreno-Arciniegas, Andrea
  • Vazirani, Ravi
  • Pérez-Herreras, Cristina
  • Marina, Pablo
  • Bueno, Héctor
  • Fernández-Friera, Leticia
  • Fernández-Ortiz, Antonio
  • Sanchez-Gonzalez, Javier
  • Ibanez, Borja
In patients with ischemic heart disease, coronary microvascular dysfunction is associated with cardiovascular risk factors and poor prognosis; however, data from healthy individuals are scarce. The purpose of this study was to assess the impact of cardiovascular risk factors and subclinical atherosclerosis on coronary microvascular function in middle-aged asymptomatic individuals. Myocardial perfusion was measured at rest and under stress using cardiac magnetic resonance in 453 individuals and used to generate myocardial blood flow (MBF) maps and calculate myocardial perfusion reserve (MPR). Subclinical atherosclerosis was assessed using 3-dimensional vascular ultrasound of the carotid and femoral arteries and coronary artery calcium scoring at baseline and at 3-year follow-up. Median participant age was 52.6 years (range: 48.9-55.8 years), and 84.5% were male. After adjusting for age and sex, rest MBF was directly associated with the number of the metabolic syndrome components present (elevated waist circumference, systolic and diastolic blood pressure, fasting glucose, and triglycerides and low high-density lipoprotein cholesterol), insulin resistance (homeostatic model assessment for insulin resistance), and presence of diabetes. MPR was reduced in the presence of several metabolic syndrome components, elevated homeostatic model assessment for insulin resistance, and diabetes. Stress MBF was inversely associated with coronary artery calcium presence and with global plaque burden. Higher stress MBF and MPR were associated with less atherosclerosis progression (increase in plaque volume) at 3 years. In asymptomatic middle-aged individuals free of known cardiovascular disease, the presence of cardiometabolic risk factors and systemic (poly-vascular) subclinical atherosclerosis are associated with impaired coronary microvascular function. Better coronary microvascular function reduces atherosclerosis progression at follow-up. (Progression of Early Subclinical Atherosclerosis [PESA]; NCT01410318).
Repisalud
Publicación Artículo científico (JournalArticle)

Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target.

  • Díaz-Guerra, Anabel
  • Villena-Gutierrez, Rocio
  • Clemente-Moragón, Agustín
  • Gomez, Monica
  • Oliver, Eduardo
  • Fernández-Tocino, Miguel
  • Galan-Arriola, Carlos
  • Cádiz, Laura
  • Ibáñez, Borja
BACKGROUND Anthracycline-induced cardiotoxicity (AIC) debilitates quality of life in cancer survivors. Serial characterizations are lacking of the molecular processes occurring with AIC. OBJECTIVES The aim of this study was to characterize AIC progression in a mouse model from early (subclinical) to advanced heart failure stages, with an emphasis on cardiac metabolism and mitochondrial structure and function. METHODS CD1 mice received 5 weekly intraperitoneal doxorubicin injections (5 mg/kg) and were followed by serial echocardiography for 15 weeks. At 1, 9, and 15 weeks after the doxorubicin injections, mice underwent fluorodeoxyglucose positron emission tomography, and hearts were extracted for microscopy and molecular analysis. RESULTS Cardiac atrophy was evident at 1 week post-doxorubicin (left ventricular [LV] mass 117 ± 26 mg vs 97 ± 25 mg at baseline and 1 week, respectively; P < 0.001). Cardiac mass nadir was observed at week 3 post-doxorubicin (79 ± 16 mg; P = 0.002 vs baseline), remaining unchanged thereafter. Histology confirmed significantly reduced cardiomyocyte area (167 ± 19 μm2 in doxorubicin-treated mice vs 211 ± 26 μm2 in controls; P = 0.004). LV ejection fraction declined from week 6 post-doxorubicin (49% ± 9% vs 61% ± 9% at baseline; P < 0.001) until the end of follow-up at 15 weeks (43% ± 8%; P < 0.001 vs baseline). At 1 week post-doxorubicin, when LV ejection fraction remained normal, reduced cardiac metabolism was evident from down-regulated markers of fatty acid oxidation and glycolysis. Metabolic impairment continued to the end of follow-up in parallel with reduced mitochondrial adenosine triphosphate production. A transient early up-regulation of nutrient-sensing and mitophagy markers were observed, which was associated with mitochondrial enlargement. Later stages, when mitophagy was exhausted, were characterized by overt mitochondrial fragmentation. CONCLUSIONS Cardiac atrophy, global hypometabolism, early transient-enhanced mitophagy, biogenesis, and nutrient sensing constitute candidate targets for AIC prevention.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Unidirectional association of clonal hematopoiesis with atherosclerosis development.

  • Díez-Díez, Miriam
  • Ramos-Neble, Beatriz L
  • de la Barrera, Jorge
  • Silla-Castro, J C
  • Quintas, Ana
  • Vázquez, Enrique
  • Rey-Martín, M Ascensión
  • Izzi, Benedetta
  • Sánchez-García, Lucía
  • García-Lunar, Inés
  • Mendieta, Guiomar
  • Mass, Virginia
  • Gómez-López, Nuria
  • Espadas, Cristina
  • González, Gema
  • Quesada, Antonio J
  • García-Álvarez, Ana
  • Fernández-Ortiz, Antonio
  • Lara-Pezzi, Enrique
  • Dopazo, Ana
  • Sánchez-Cabo, Fátima
  • Ibáñez, Borja
  • Andrés, Vicente
  • Fuster, Valentín
  • Fuster, José J
Clonal hematopoiesis, a condition in which acquired somatic mutations in hematopoietic stem cells lead to the outgrowth of a mutant hematopoietic clone, is associated with a higher risk of hematological cancer and a growing list of nonhematological disorders, most notably atherosclerosis and associated cardiovascular disease. However, whether accelerated atherosclerosis is a cause or a consequence of clonal hematopoiesis remains a matter of debate. Some studies support a direct contribution of certain clonal hematopoiesis-related mutations to atherosclerosis via exacerbation of inflammatory responses, whereas others suggest that clonal hematopoiesis is a symptom rather than a cause of atherosclerosis, as atherosclerosis or related traits may accelerate the expansion of mutant hematopoietic clones. Here we combine high-sensitivity DNA sequencing in blood and noninvasive vascular imaging to investigate the interplay between clonal hematopoiesis and atherosclerosis in a longitudinal cohort of healthy middle-aged individuals. We found that the presence of a clonal hematopoiesis-related mutation confers an increased risk of developing de novo femoral atherosclerosis over a 6-year period, whereas neither the presence nor the extent of atherosclerosis affects mutant cell expansion during this timeframe. These findings indicate that clonal hematopoiesis unidirectionally promotes atherosclerosis, which should help translate the growing understanding of this condition into strategies for the prevention of atherosclerotic cardiovascular disease in individuals exhibiting clonal hematopoiesis.
Repisalud
Publicación Artículo científico (JournalArticle)

Remote ischemic conditioning protects against anthracycline cardiotoxicity without impairing its antitumor activity.

  • Díaz-Guerra, Anabel
  • Clemente-Moragón, Agustín
  • Pollán, Ángela
  • López-Palomar, Lucía
  • Cádiz, Laura
  • Ibáñez, Borja
Anthracyclines remain a cornerstone of treatment for many cancer types; however, their cardiotoxic potential leads to cardiac dysfunction in a substantial proportion of patients, ultimately compromising long-term quality of life. Few strategies have proven effective in preventing anthracycline-induced cardiotoxicity (AIC). Among them, remote ischemic conditioning (RIC) has emerged as one of the most promising, having shown robust cardioprotective potential in preclinical studies and currently being evaluated in clinical trials. However, it remains unclear whether this intervention, while protecting the heart, could also inadvertently protect tumors from the cytotoxic effects of anthracyclines, thereby reducing their antitumor efficacy. In this study, we investigated whether RIC protects against AIC in a tumor-bearing mouse model, allowing simultaneous assessment of both cardiac and tumoral responses. Cutaneous tumors were induced in CD1 mice using a DMBA/TPA protocol, followed by five weekly intraperitoneal injections of doxorubicin (5 mg/kg). Mice bearing tumors were randomized to receive doxorubicin alone or in combination with weekly RIC (three cycles of 5 min hindlimb ischemia/reperfusion). Longitudinal echocardiography was used to assess cardiac function, while tumor growth, survival, and body weight were monitored throughout the protocol. Doxorubicin treatment reduced overall survival, inhibited tumor growth, and induced left ventricular systolic dysfunction and cardiac atrophy compared with untreated controls. RIC preserved left ventricular ejection fraction, partially attenuated early left ventricular atrophy, and showed a trend towards improved survival, without attenuating the antitumor efficacy of doxorubicin, as tumor suppression remained comparable between treatment groups. These findings demonstrate that RIC preserves cardiac systolic function during anthracycline chemotherapy in tumor-bearing mice without impairing the antitumor efficacy of the drug. The results support RIC as a simple, safe, and low-cost non-pharmacological strategy to mitigate AIC with potential translational relevance for oncology patients.
Repisalud
Publicación Artículo científico (JournalArticle)

Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.

  • Moreno-Arciniegas, Andrea
  • García, Alberto
  • Kelm, Malte
  • D'Amore, Francesco
  • da Silva, María Gomes
  • Sánchez-González, Javier
  • Sánchez, Pedro L
  • López-Fernández, Teresa
  • Córdoba, Raul
  • Asteggiano, Riccardo
  • Camus, Vincent
  • Smink, Jouke
  • Ferreira, Antonio
  • Kersten, Marie J
  • Bolaños, Natacha
  • Escalera, Noemi
  • Pacella, Elsa
  • Gómez-Talavera, Sandra
  • Quesada, Antonio
  • Rosselló, Xavier
  • Ibanez, Borja
There is a lack of therapies able to prevent anthracycline cardiotoxicity (AC). Remote ischaemic conditioning (RIC) has shown beneficial effects in preclinical models of AC. REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs (RESILIENCE) is a multinational, prospective, phase II, double-blind, sham-controlled, randomized clinical trial that evaluates the efficacy and safety of RIC in lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles including anthracyclines and with ≥1 AC-associated risk factors will be randomized to weekly RIC or sham throughout the chemotherapy period. Patients will undergo three multiparametric cardiac magnetic resonance (CMR) studies, at baseline, after the third cycle (intermediate CMR), and 2 months after the end of chemotherapy. Thereafter, patients will be followed up for clinical events over an anticipated median of ≥24 months. The primary endpoint is the absolute change from baseline in CMR-based left ventricular ejection fraction (LVEF). The main secondary outcome is the incidence of AC events, defined as (1) a drop in CMR-based LVEF of ≥10 absolute points, or (2) a drop in CMR-based LVEF of ≥5 and <10 absolute points to a value <50%. Intermediate CMR will test the ability of T2 mapping to predict AC versus classical markers (left ventricular strain and cardiac injury biomarkers). A novel CMR sequence allowing ultrafast cine acquisition will be validated in this vulnerable population. The RESILIENCE trial will test RIC (a novel non-invasive intervention to prevent AC) in a cohort of high-risk patients. The trial will also test candidate markers for their capacity to predict AC and will validate a novel CMR sequence reducing acquisition time in a vulnerable population.
Repisalud
Publicación Artículo científico (JournalArticle)

Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.

  • Ghigo, Alessandra
  • Ameri, Pietro
  • Asnani, Aarti
  • Bertero, Edoardo
  • de Boer, Rudolf A
  • Farmakis, Dimitrios
  • González, Arantxa
  • Heymans, Stephane
  • Ibáñez, Borja
  • López-Fernández, Teresa
  • Lyon, Alexander R
  • Pollesello, Piero
  • Rakisheva, Amina
  • Stellos, Konstantinos
  • Streckfuss-Bömeke, Katrin
  • Tocchetti, Carlo Gabriele
  • Thum, Thomas
  • van der Meer, Peter
  • Van Rooij, Eva
  • Ponikowski, Piotr
  • Metra, Marco
  • Rosano, Giuseppe
  • Van Linthout, Sophie
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the implementation of effective treatments. Therefore, there is a crucial need for appropriate preclinical models to understand the biological basis of their cardiotoxicity. This scientific statement summarizes the preclinical models hitherto used, from in vitro two- and three-dimensional human systems to small and large animals, to pinpoint the molecular mechanisms behind the cardiotoxicity of new-generation anticancer therapies, particularly immunotherapies, and to develop potential cardioprotective strategies. Furthermore, it discusses how preclinical models have contributed to the provocative concept of heart failure being potentially tumorigenic and how the discovery of drugs with both anticancer and cardioprotective actions has revealed a common mechanistic basis for heart failure and cancer. Finally, it discusses the existing gaps between preclinical models and clinical observations in patients, how these discrepancies affect regulatory pathways and the drug development process in cardio-oncology and provides recommendations for closing these gaps.
Repisalud
Publicación Artículo científico (JournalArticle)

The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity.

Repisalud
Publicación Artículo de revisión (ReviewArticle)

Cardioprotection strategies for anthracycline cardiotoxicity.

  • Moreno-Arciniegas, Andrea
  • Cádiz, Laura
  • Galán-Arriola, Carlos
  • Clemente-Moragón, Agustín
  • Ibáñez, Borja
Thanks to the fantastic progress in cancer therapy options, there is a growing population of cancer survivors. This success has resulted in a need to focus much effort into improving the quality of life of this population. Cancer and cardiovascular disease share many common risk factors and have an interplay between them, with one condition mechanistically affecting the other and vice versa. Furthermore, widely prescribed cancer therapies have known toxic effects in the cardiovascular system. Anthracyclines are the paradigm of efficacious cancer therapy widely prescribed with a strong cardiotoxic potential. While some cancer therapies cardiovascular toxicities are transient, others are irreversible. There is a growing need to develop cardioprotective therapies that, when used in conjunction with cancer therapies, can prevent cardiovascular toxicity and thus improve long-term quality of life in survivors. The field has three main challenges: (i) identification of the ultimate mechanisms leading to cardiotoxicity to (ii) identify specific therapeutic targets, and (iii) more sensible diagnostic tools to early identify these conditions. In this review we will focus on the cardioprotective strategies tested and under investigation. We will focus this article into anthracycline cardiotoxicity since it is still the agent most widely prescribed, the one with higher toxic effects on the heart, and the most widely studied.
Repisalud
Publicación Artículo científico (JournalArticle)

The impact of type 2 immunity and allergic diseases in atherosclerosis.

  • Fernández-Gallego, Nieves
  • Castillo-González, Raquel
  • Méndez-Barbero, Nerea
  • López-Sanz, Celia
  • Obeso, David
  • Villaseñor, Alma
  • Escribese, María M
  • López-Melgar, Beatriz
  • Salamanca, Jorge
  • Benedicto-Buendía, Amparo
  • Jiménez-Borreguero, Luis Jesús
  • Ibáñez, Borja
  • Sastre, Joaquín
  • Belver, María Teresa
  • Vega, Francisco
  • Blanco, Carlos
  • Barber, Domingo
  • Sánchez-Madrid, Francisco
  • de la Fuente, Hortensia
  • Martin, Pilar
  • Esteban, Vanesa
  • Jiménez-Saiz, Rodrigo
  • Fernández‐Gallego, Nieves
  • Castillo‐González, Raquel
  • Méndez‐Barbero, Nerea
  • López‐Sanz, Celia
  • Escribese, María M.
  • López‐Melgar, Beatriz
  • Benedicto‐Buendía, Amparo
  • Jiménez‐Borreguero, Luis Jesús
  • Sánchez‐Madrid, Francisco
  • Jiménez‐Saiz, Rodrigo
Allergic diseases are allergen-induced immunological disorders characterized by the development of type 2 immunity and IgE responses. The prevalence of allergic diseases has been on the rise alike cardiovascular disease (CVD), which affects arteries of different organs such as the heart, the kidney and the brain. The underlying cause of CVD is often atherosclerosis, a disease distinguished by endothelial dysfunction, fibrofatty material accumulation in the intima of the artery wall, smooth muscle cell proliferation, and Th1 inflammation. The opposed T-cell identity of allergy and atherosclerosis implies an atheroprotective role for Th2 cells by counteracting Th1 responses. Yet, the clinical association between allergic disease and CVD argues against it. Within, we review different phases of allergic pathology, basic immunological mechanisms of atherosclerosis and the clinical association between allergic diseases (particularly asthma, atopic dermatitis, allergic rhinitis and food allergy) and CVD. Then, we discuss putative atherogenic mechanisms of type 2 immunity and allergic inflammation including acute allergic reactions (IgE, IgG1, mast cells, macrophages and allergic mediators such as vasoactive components, growth factors and those derived from the complement, contact and coagulation systems) and late phase inflammation (Th2 cells, eosinophils, type 2 innate-like lymphoid cells, alarmins, IL-4, IL-5, IL-9, IL-13 and IL-17).
Repisalud
Publicación Artículo científico (JournalArticle)

Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control

  • Díaz-Guerra, Anabel
  • Villena-Gutiérrez, Rocío
  • Clemente-Moragón, Agustín
  • Gómez, Mónica
  • Oliver, Eduardo
  • Fernández-Tocino, Miguel
  • Galán-Arriola, Carlos
  • Cádiz, Laura
  • Ibáñez, Borja
Repisalud
Publicación Artículo científico (JournalArticle)

Comparative proteomic analysis of nuclear and cytoplasmic compartments in human cardiac progenitor cells.

  • Albericio, Guillermo
  • Aguilar, Susana
  • Torán, Jose Luis
  • Yañez, Rosa
  • López, Juan Antonio
  • Vazquez, Jesus
  • Mora, Carmen
  • Bernad, Antonio
Clinical trials evaluating cardiac progenitor cells (CPC) demonstrated feasibility and safety, but no clear functional benefits. Therefore a deeper understanding of CPC biology is warranted to inform strategies capable to enhance their therapeutic potential. Here we have defined, using a label-free proteomic approach, the differential cytoplasmic and nuclear compartments of human CPC (hCPC). Global analysis of cytoplasmic repertoire in hCPC suggested an important hypoxia response capacity and active collagen metabolism. In addition, comparative analysis of the nuclear protein compartment identified a significant regulation of a small number of proteins in hCPC versus human mesenchymal stem cells (hMSC). Two proteins significantly upregulated in the hCPC nuclear compartment, IL1A and IMP3, showed also a parallel increase in mRNA expression in hCPC versus hMSC, and were studied further. IL1A, subjected to an important post-transcriptional regulation, was demonstrated to act as a dual-function cytokine with a plausible role in apoptosis regulation. The knockdown of the mRNA binding protein (IMP3) did not negatively impact hCPC viability, but reduced their proliferation and migration capacity. Analysis of a panel of putative candidate genes identified HMGA2 and PTPRF as IMP3 targets in hCPC. Therefore, they are potentially involved in hCPC proliferation/migration regulation.
Repisalud
Publicación Artículo científico (JournalArticle)

Four-Dimensional Magnetic Resonance Pulmonary Flow Imaging for Assessing Pulmonary Vasculopathy in Patients with Postcapillary Pulmonary Hypertension.

  • Nuche, Jorge
  • Ponz, Inés
  • Sánchez Sánchez, Violeta
  • Bóbeda, Javier
  • Gaitán, Ángel
  • López-Linares, Karen
  • García-Cosío, María Dolores
  • Sarnago Cebada, Fernando
  • González, Javier Sánchez
  • Arribas Ynsaurriaga, Fernando
  • Ruíz-Cabello, Jesús
  • Ibáñez, Borja
  • Delgado, Juan F
Noninvasive techniques for diagnosing combined postcapillary pulmonary hypertension (CpcPH) are unavailable. : To assess the diagnostic performance of cardiac magnetic resonance (CMR)-based four-dimensional (4D)-flow analysis in identifying CpcPH. : Prospective observational study of heart failure (HF) patients with suspected pulmonary hypertension (PH) who underwent simultaneous CMR and right heart catheterization. The 4D-flow biomarkers were calculated using an automatic pipeline. A predictive model including 4D-flow biomarkers associated with CpcPH with a -value < 0.20 was built to determine the diagnostic performance of 4D-flow analysis to identify CpcPH. : A total of 46 HF patients (55.4 ± 14 years, 63% male) with confirmed PH (19 [41%] isolated postcapillary PH [IpcPH], 27 [59%] CpcPH) were included. No differences were found in baseline characteristics, echocardiography, or CMR anatomical and functional parameters, except for a higher Doppler-estimated systolic pulmonary pressure and larger pulmonary artery in CpcPH patients. The 4D-flow CMR analysis was performed in 31 patients (67%). The maximal peak velocity (67.1 [62.2-77.5] cm/s-IpcPH vs. 58.2 [45.8-66.0] cm/s-CpcPH; = 0.021) and maximal helicity (339.9 [290.0-391.8]) cm/s-IpcPH vs. 226.0 (173.5-343.7) cm/s-CpcPH; = 0.026) were significantly lower in patients with CpcPH. A maximal multivariable model including sex, maximal average, and peak velocities, Reynolds number, flow rate, and helicity showed fair diagnostic performance (area under the curve: 0.768 [95%-CI: 0.572-0.963]; sensitivity: 100%; specificity: 55%). : In HF patients with PH, 4D-flow-derived maximal peak velocity and maximal helicity were significantly lower in CpcPH patients. A multiparametric model including maximal 4D-flow-derived biomarkers showed good diagnostic performance for identifying CpcPH.
Repisalud
Publicación Artículo científico (JournalArticle)

Bone marrow activation in response to metabolic syndrome and early atherosclerosis

  • Devesa, Ana
  • Lobo-González, Manuel
  • Martínez-Milla, Juan
  • Oliva, Belén
  • García-Lunar, Inés
  • Mastrangelo, Annalaura
  • España, Samuel
  • Sanz, Javier
  • Mendiguren, José M
  • Bueno, Hector
  • Fuster, Jose J.
  • Andres, Vicente
  • Fernández-Ortiz, Antonio
  • Sancho, David
  • Fernández-Friera, Leticia
  • Sanchez-Gonzalez, Javier
  • Rossello, Xavier
  • Ibáñez, Borja
  • Fuster, Valentin
Aims: Experimental studies suggest that increased bone marrow (BM) activity is involved in the association between cardiovascular risk factors and inflammation in atherosclerosis. However, human data to support this association are sparse. The purpose was to study the association between cardiovascular risk factors, BM activation, and subclinical atherosclerosis. Methods and results: Whole body vascular 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) was performed in 745 apparently healthy individuals [median age 50.5 (46.8-53.6) years, 83.8% men] from the Progression of Early Subclinical Atherosclerosis (PESA) study. Bone marrow activation (defined as BM 18F-FDG uptake above the median maximal standardized uptake value) was assessed in the lumbar vertebrae (L3-L4). Systemic inflammation was indexed from circulating biomarkers. Early atherosclerosis was evaluated by arterial metabolic activity by 18F-FDG uptake in five vascular territories. Late atherosclerosis was evaluated by fully formed plaques on MRI. Subjects with BM activation were more frequently men (87.6 vs. 80.0%, P = 0.005) and more frequently had metabolic syndrome (MetS) (22.2 vs. 6.7%, P < 0.001). Bone marrow activation was significantly associated with all MetS components. Bone marrow activation was also associated with increased haematopoiesis-characterized by significantly elevated leucocyte (mainly neutrophil and monocytes) and erythrocyte counts-and with markers of systemic inflammation including high-sensitivity C-reactive protein, ferritin, fibrinogen, P-selectin, and vascular cell adhesion molecule-1. The associations between BM activation and MetS (and its components) and increased erythropoiesis were maintained in the subgroup of participants with no systemic inflammation. Bone marrow activation was significantly associated with high arterial metabolic activity (18F-FDG uptake). The co-occurrence of BM activation and arterial 18F-FDG uptake was associated with more advanced atherosclerosis (i.e. plaque presence and burden). Conclusion: In apparently healthy individuals, BM 18F-FDG uptake is associated with MetS and its components, even in the absence of systemic inflammation, and with elevated counts of circulating leucocytes. Bone marrow activation is associated with early atherosclerosis, characterized by high arterial metabolic activity. Bone marrow activation appears to be an early phenomenon in atherosclerosis development.[Progression of Early Subclinical Atherosclerosis (PESA); NCT01410318].Whole body vascular 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) was performed in 745 apparently healthy individuals [median age 50.5 (46.8-53.6) years, 83.8% men] from the Progression of Early Subclinical Atherosclerosis (PESA) study. Bone marrow activation (defined as BM 18F-FDG uptake above the median maximal standardized uptake value) was assessed in the lumbar vertebrae (L3-L4). Systemic inflammation was indexed from circulating biomarkers. Early atherosclerosis was evaluated by arterial metabolic activity by 18F-FDG uptake in five vascular territories. Late atherosclerosis was evaluated by fully formed plaques on MRI. Subjects with BM activation were more frequently men (87.6 vs. 80.0%, P = 0.005) and more frequently had metabolic syndrome (MetS) (22.2 vs. 6.7%, P < 0.001). Bone marrow activation was significantly associated with all MetS components. Bone marrow activation was also associated with increased haematopoiesis-characterized by significantly elevated leucocyte (mainly neutrophil and monocytes) and erythrocyte counts-and with markers of systemic inflammation including high-sensitivity C-reactive protein, ferritin, fibrinogen, P-selectin, and vascular cell adhesion molecule-1. The associations between BM activation and MetS (and its components) and increased erythropoiesis were maintained in the subgroup of participants with no systemic inflammation. Bone marrow activation was significantly associated with high arterial metabolic activity (18F-FDG uptake). The co-occurrence of BM activation and arterial 18F-FDG uptake was associated with more advanced atherosclerosis (i.e. plaque presence and burden). In apparently healthy individuals, BM 18F-FDG uptake is associated with MetS and its components, even in the absence of systemic inflammation, and with elevated counts of circulating leucocytes. Bone marrow activation is associated with early atherosclerosis, characterized by high arterial metabolic activity. Bone marrow activation appears to be an early phenomenon in atherosclerosis development.[Progression of Early Subclinical Atherosclerosis (PESA); NCT01410318].
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

A synbiotics, long chain polyunsaturated fatty acids, and milk fat globule membranes supplemented formula modulates microbiota maturation and neurodevelopment

  • Cerdó Ráez, Tomás
  • Ruiz Rodríguez, Alicia
  • Acuña Morales, Inmaculada
  • Nieto Ruiz, Ana María
  • Diéguez Castillo, Estefanía
  • Sepúlveda Valbuena, Natalia
  • Escudero Marín, Mireia
  • García Santos, José Antonio
  • García Ricobaraza, María
  • Herrmann, Florian
  • Moreno-Muñoz, José Antonio
  • De Castellar, Roser
  • Jiménez, Jesús
  • Suárez García, Antonio Francisco|||0000-0002-1006-7490
  • Campoy Folgoso, Cristina|||0000-0002-9860-6785
Supplementary data to this article can be found online at https://doi.org/10.1016/j.clnu.2022.05.013., Acknowledgments The authors wish to acknowledge the parents and children who participated in the study, and also the paediatricians and researchers of the EURISTIKOS team at the Department of Paediatrics as well as the Genetics Service at Centro de Instrumentación Científica e UGR for their contributions., Funding This project was supported by CDTI (Centro para el Desarrollo Tecnológico e Industrial) and FEDER (SMARTFOODS: IDI-20141206), Ordesa Laboratories, S.L. (Contract FE-UGR No. 3349), and The Spanish Ministry of Economy, Industry and Competitiveness, and partially supported by HORIZON 2020 EU DynaHEALTH Project (GA No.633595). Alicia Ruiz and Inmaculada Acuña were granted Ph.D. scholarships from the Spanish Ministry of Economy and Competitivity. Tomás Cerdó was granted a Ph.D. scholarship from Carlos III Health Institute. Natalia Sepúlveda-Valbuena was granted with a scholarship from Fundación Carolina, Madrid, Spain., Background & aims The critical window of concurrent developmental paths of the nervous system and gut microbiota in infancy provides an opportunity for nutritional interventions with potential health benefits later in life. Methods We compared the dynamics of gut microbiota maturation and explored its association with neurodevelopment at 12 months and 4 years of age in 170 full-term healthy infants fed a standard formula (SF) or a new formula (EF) based on standard formula supplemented with synbiotics, long chain polyunsaturated fatty acids (LC-PUFA) and bovine milk fat globule membranes (MFGM), including a breastfed reference group (BF). Results Using Dirichlet Multinomial Modelling, we characterized three microbial enterotypes (Mixed, anaerobic and aerobic profile; Bact, Bacteroides-dominant; Firm, Firmicutes-enriched) and identified a new enterotype dominated by an unidentified genus within Lachnospiraceae (U_Lach). Enterotypes were associated with age (Mixed with baseline, U_Lach with month 6, Bact and Firm with months 12 and 18). Trajectories or timely enterotype shifts in each infant were not random but strongly associated with type of feeding. Trajectories in SF shifted from initial Mixed to U_Lach, Bact or Firm at month. Microbiota maturation in EF split into a fast trajectory as in SF, and a slow trajectory with Mixed to U_Lach, Bact or Firm transitions at months 12 or 18, as in BF. EF infants with slow trajectories were more often in–home reared and born by vaginal delivery to mothers with pre-pregnancy lean BMI. At 12 months of age, language and expressive language scores were significantly higher in EF infants with fast trajectories than in BF. Neurodevelopmental outcomes were similar between EF infants with slow trajectories and BF at 12 months and 4 years of age. Conclusions Feeding a synbiotics, LC-PUFA and MFGM supplemented formula in a specific infant environment promoted probiotic growth and retarded gut microbiota maturation with similar neurodevelopment outcomes to breastfed infants., CDTI (Centro para el Desarrollo Tecnológico e Industrial) and FEDER (SMARTFOODS: IDI- 20141206), Ordesa Laboratories, S.L. (Contract FE-UGR No. 3349), Spanish Ministry of Economy, Industry and Competitiveness, HORIZON 2020 EU DynaHEALTH Project (GA No.633595)
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Plant foods, dietary fibre and risk of ischaemic heart disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

  • Pérez-Cornago, Aurora
  • Petrova, Dafina
Analyses were supported by the UK Medical Research Council (MR/M012190/1), Cancer Research UK (C8221/A19170 and 570/A16491) and the Wellcome Trust (Our Planet Our Health, Livestock Environment and People 205212/Z/16/Z). A.P.C. is supported by a Cancer Research UK Population Research Fellowship (C60192/A28516) and by the World Cancer Research Fund (WCRF UK), as part of the Word Cancer Research Fund International grant programme (2019/1953). EPIC-CVD has been supported by the European Union Framework 7 (HEALTH-F2-2012-279233), the European Research Council (268834), the UK Medical Research Council (G0800270 and MR/L003120/1), the British Heart Foundation (SP/09/002 and RG/08/014 and RG13/13/30194) and the UK National Institute of Health Research. The InterAct project was funded by the EU FP6 programme (grant number LSHM_CT_2006_037197) and provided the biomarker data in the sub-cohort that was used in the current study. The coordination of EPIC is financially supported by the European Commission (DGSANCO) and the International Agency for Research on Cancer. The national cohorts are supported by: Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Ge ' ne ' rale de l'Education Nationale, Institut National de la Sante ' et de la Recherche Me ' dicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF) (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF); Health Research Fund (FIS), PI13/00061 to Granada, PI13/01162 to EPIC-Murcia, Regional Governments of Andaluci ' a, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Ska degrees ne and Va<spacing diaeresis> sterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), UK Medical Research Council [1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford, MC_UU_12015/1 (N.J.W.), MC_UU_12015/5 (NGF), and MC_UU_12015/520], and NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme (IS-BRC-1215-20014) to the MRC Epidemiology Unit Cambridge (N.J.W., N.G.F.). J.D. holds a British Heart Foundation Chair and an NIHR Senior Investigator Award. K.E.B. holds a Girdlers' New Zealand Health Research Council Fellowship. J.D. is funded by the National Institute for Health Research [Senior Investigator Award] [*]. A.W is supported by a BHF-Turing Cardiovascular Data Science Award and by the ECInnovative Medicines Initiative (BigData@Heart).M.S.reports funding from the Alpro Foundation whilst at the Cardiovascular Epidemiology Unit (up to 15-08-2016), and Core MRC Unit support through the Nutritional Epidemiology Programme (MC_UU_12015/5) whilst at the MRC Epidemiology Unit (15-08-2016 until now), during the conduct of the study., The authors thank all participants in the EPIC cohort for their invaluable contribution to the study., Epidemiological evidence indicates that diets rich in plant foods are associated with a lower risk of ischaemic heart disease (IHD), but there is sparse information on fruit and vegetable subtypes and sources of dietary fibre. This study examined the associations of major plant foods, their subtypes and dietary fibre with risk of IHD in the European Prospective Investigation into Cancer and Nutrition (EPIC). Methods We conducted a prospective analysis of 490 311 men and women without a history of myocardial infarction or stroke at recruitment (12.6 years of follow-up, n cases = 8504), in 10 European countries. Dietary intake was assessed using validated questionnaires, calibrated with 24-h recalls. Multivariable Cox regressions were used to estimate hazard ratios (HR) of IHD. Results There was a lower risk of IHD with a higher intake of fruit and vegetables combined [HR per 200 g/day higher intake 0.94, 95% confidence interval (CI): 0.90–0.99, P-trend = 0.009], and with total fruits (per 100 g/day 0.97, 0.95–1.00, P-trend = 0.021). There was no evidence for a reduced risk for fruit subtypes, except for bananas. Risk was lower with higher intakes of nuts and seeds (per 10 g/day 0.90, 0.82–0.98, P-trend = 0.020), total fibre (per 10 g/day 0.91, 0.85–0.98, P-trend = 0.015), fruit and vegetable fibre (per 4 g/day 0.95, 0.91–0.99, P-trend = 0.022) and fruit fibre (per 2 g/day 0.97, 0.95–1.00, P-trend = 0.045). No associations were observed between vegetables, vegetables subtypes, legumes, cereals and IHD risk. Conclusions In this large prospective study, we found some small inverse associations between plant foods and IHD risk, with fruit and vegetables combined being the most strongly inversely associated with risk. Whether these small associations are causal remains unclear., UK Research & Innovation (UKRI) Medical Research Council UK (MRC) MR/M012190/1 G0800270 MR/L003120/1 1000143 MC_UU_12015/1 MC_UU_12015/5 MC_UU_12015/520, Cancer Research UK C8221/A19170 570/A16491 14136 C570/A16491, Wellcome Trust (Our Planet Our Health, Livestock Environment and People) 205212/Z/16/Z, Cancer Research UK Population Research Fellowship C60192/A28516, World Cancer Research Fund (WCRF UK), as part of the Word Cancer Research Fund International grant programme 2019/1953, European Commission HEALTH-F2-2012-279233, European Research Council (ERC) European Commission 268834, British Heart Foundation SP/09/002 RG/08/014 RG13/13/30194, National Institute for Health Research (NIHR), European Commission LSHM_CT_2006_037197, European Commission European Commission Joint Research Centre, International Agency for Research on Cancer, Danish Cancer Society, Ligue Contre le Cancer (France), Institut Gustave Roussy (France), Mutuelle Generale de l'Education Nationale (France), Institut National de la Sante et de la Recherche Medicale (Inserm), Deutsche Krebshilfe, German Cancer Research Center (DKFZ) (Germany), Federal Ministry of Education & Research (BMBF), Hellenic Health Foundation (Greece), Associazione Italiana per la Ricerca sul Cancro (AIRC), Consiglio Nazionale delle Ricerche (CNR), Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Netherlands Organization for Scientific Research (NWO), World Cancer Research Fund International (WCRF), Instituto de Salud Carlos III PI13/00061 PI13/01162, Junta de Andalucia, Regional Government of Asturias (Spain), Regional Government of Basque Country (Spain), Regional Government of Murcia (Spain) 6236, Regional Government of Navarra (Spain), Instituto de Salud Carlos III RD06/0020, Swedish Cancer Society, Swedish Research Council, County Council of Skane (Sweden), County Council of Vasterbotten (Sweden), NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme IS-BRC-1215-20014, British Heart Foundation, NIHR Senior Investigator Award, Girdlers' New Zealand Health Research Council Fellowship, National Institute for Health Research (NIHR), BHF-Turing Cardiovascular Data Science Award, ECInnovative Medicines Initiative (BigData@Heart), Alpro Foundation 15-08-2016, Core MRC Unit support through the Nutritional Epidemiology Programme MC_UU_12015/5
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Long-Term Effects and Potential Impact of Early Nutrition with Breast Milk or Infant Formula on Glucose Homeostasis Control in Healthy Children at 6 Years Old: A Follow-Up from the COGNIS Study

  • Diéguez Castillo, Estefanía
  • Nieto Ruiz, Ana María
  • Herrmann, Florian
  • Agil Abdalla, Mhmad Ahmad
  • Azaryah, Hatim
  • García Santos, José Antonio
  • García Bermúdez, María Mercedes
  • Campoy Folgoso, Cristina|||0000-0002-9860-6785
There is scarce evidence about early nutrition programming of dynamic aspects of glucose homeostasis. We analyzed the long-term effects of early nutrition on glycemic variability in healthy children. A total of 92 children participating in the COGNIS study were considered for this analysis, who were fed with: a standard infant formula (SF, n = 32), an experimental formula (EF, n = 32), supplemented with milk fat globule membrane (MFGM) components, long-chain polyunsaturated fatty acids (LC-PUFAs), and synbiotics, or were breastfed (BF, n = 28). At 6 years old, BF children had lower mean glucose levels and higher multiscale sample entropy (MSE) compared to those fed with SF. No differences in MSE were found between EF and BF groups. Normal and slow weight gain velocity during the first 6 months of life were associated with higher MSE at 6 years, suggesting an early programming effect against later metabolic disorders, thus similarly to what we observed in breastfed children. Conclusion: According to our results, BF and normal/slow weight gain velocity during early life seem to protect against glucose homeostasis dysregulation at 6 years old. EF shows functional similarities to BF regarding children’s glucose variability. The detection of glucose dysregulation in healthy children would help to develop strategies to prevent the onset of metabolic disorders in adulthood, Randox Laboratories, Contract University of Granada General Foundation, SMARTFOODS (CIEN) Contract University of Granada General Foundation, Spanish Government, HORIZON 2020 EU DynaHEALTH Project 633595, Junta de Andalucia Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades 404, Fundacion Carolina, Madrid, Spain
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Tesis doctoral (DoctoralThesis)

Efectos de la nutrición precoz sobre la programación del control glucémico en el niño

  • Diéguez Castillo, Estefanía
Tesis Univ. Granada., Laboratorios Ordesa, S.L. Contrato de la Fundación General de la Universidad de Granada, Ref. nº 3349, Proyecto Inter-empresas SMARTFOODS (CIENIDI- 20141206), Ministerio de Economía, Industria y Competitividad de España, (Contrato Fundación General Universidad de Granada, Ref. nº 4003, Proyecto Europeo HORIZON 2020 DynaHEALTH (GA No. 633595)
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Growth patterns and breast milk/infant formula energetic efficiency in healthy infants up to 18 months of life: the COGNIS study

  • Sepúlveda Valbuena, Natalia
  • Nieto-Ruiz, Ana
  • Diéguez Castillo, Estefanía
  • Herrmann, Florian
  • Escudero Marín, Mireia
  • De Castellar, Roser
  • Rodríguez-Palmero, Maria
  • Miranda León, María Teresa|||0000-0002-6254-7402
  • García Santos, José Antonio
  • García Bermúdez, María Mercedes
  • Campoy Folgoso, Cristina|||0000-0002-9860-6785
This project has been funded by Laboratorios Ordesa, S. L. Contract University of Granada General Foundation, No. 3349 and SMARTFOODS (CIEN) Contract University of Granada General Foundation, No. 4003, Spanish Ministry of Economy, Industry and Competitiveness, and partially funded by HORIZON 2020 EU DynaHEALTH Project (GA No.633595). N. S-V. has been granted with a scholarship from Fundaci ' on Carolina, Madrid, Spain., Type of feeding during early life influences growth trajectory and metabolic risk at later ages. Modifications in infant formula composition have led to evaluate their effects on growth and energetic efficiency (EE) compared with breast-feeding. Main goal was to analyse type of feeding potential effects during first months of life, plus its EE, on growth patterns in healthy formula fed (standard infant formula (SF) vs. experimental infant formula enriched with bioactive nutrients (EF)) and breastfed (BF) infants participating in the COGNIS RCT (http://www.ClinicalTrials.gov, Identifier: NCT02094547) up to 18 months of age. Infants follow-up to 18 months of age (n 141) fed with a SF (n 48), EF(n 56), or BF (n 37), were assessed for growth parameters using WHO standards. Growth velocity (GV) and catch-up were calculated to identify growth patterns. EE of breast milk/infant formula was also estimated. Infants' growth at 6 months showed higher length and lower head circumference gains in SF and EF infants than BF infants. Both weight-for-length and weight-for-age catch-up growth showed significant differences in formula fed groups compared with the BF. No significant differences in GV or catch-up were found at 6-12 and 12-18 months. Regarding EE, infant formula groups showed significantly lower weight and length gains/g of milk protein, and higher weight and length gains/g of milk lipids, than the BF infants. GV during first 6 months, which may be influenced by feeding, seems to be the main predictor of subsequent growth trajectory. Breast-feeding may have positive effects on growth programming due to its nutrients' EE., Laboratorios Ordesa, S. L. Contract University of Granada General Foundation 3349, SMARTFOODS (CIEN) Contract University of Granada General Foundation 4003, Spanish Ministry of Economy, Industry and Competitiveness, HORIZON 2020 EU DynaHEALTH Project 633595, Fundacion Carolina, Madrid, Spain
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Almond by-products: valorization for sustainability and competitiveness of the industry

  • Barral Martinez, Marta
  • Fraga Corral, María
  • García Pérez, Pascual
  • Simal Gándara, Jesús
  • Prieto Lage, Miguel Ángel
The search for waste minimization and the valorization of by-products are key practices for good management and improved sustainability in the food industry. The production of almonds generates a large amount of waste, most of which is not used. Until now, almonds have been used for their high nutritional value as food, especially almond meat. The other remaining parts (skin, shell, hulls, etc.) are still little explored, even though they have been used as fuel by burning or as livestock feed. However, interest in these by-products has been increasing as they possess beneficial properties (caused mainly by polyphenols and unsaturated fatty acids) and can be used as new ingredients for the food, cosmetic, and pharmaceutical industries. Therefore, it is important to explore almond’s valorization of by-products for the development of new added-value products that would contribute to the reduction of environmental impact and an improvement in the sustainability and competitiveness of the almond industry., CYTED—AQUA-CIBUS | Ref. P317RT0003
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Health promoting properties of bee royal jelly: food of the queens

  • Collazo, Nicolas
  • Carpena Rodríguez, María
  • Núñez Estévez, Bernabé
  • Otero, Paz
  • Simal Gándara, Jesús
  • Prieto Lage, Miguel Ángel
Royal jelly (RJ) demand is growing every year and so is the market for functional foods in general. RJ is formed by different substances, mainly carbohydrates, proteins, and lipids, but also vitamins, minerals, and phenolic or volatile compounds in lower proportion. Major royal jelly proteins (MRJP) are, together with 10-hydroxy-2-decenoic acid (10-HDA), key substances of RJ due to their different biological properties. In particular, 10-HDA is a unique substance in this product. RJ has been historically employed as health enhancer and is still very relevant in China due to the traditional medicine and the apitherapy. Nowadays, it is mainly consumed as a functional food or is found in supplements and other formulations for its health-beneficial properties. Within these properites, anti-lipidemic, antioxidant, antiproliferative, antimicrobial, neuroprotective, anti-inflammatory, immunomodulatory, antiaging, and estrogenic activities have been reported for RJ or its specific components. This manuscript is aimed at reviewing the current knowledge on RJ components, their assessment in terms of authenticity, their biological activities, and related health applications., European Commission | Ref. 0377_IBERPHENOL_6_E, European Commission | Ref. 0181_NANOEATERS_ 01_E, Xunta de Galicia | Ref. IN852A, Xunta de Galicia | Ref. ED431F 2020/12, Ministerio de Economía, Industria y Competitividad | Ref. RYC-2017-22891, CYTED—AQUA-CIBUS | Ref. P317RT0003
Dehesa. Repositorio Institucional de la Universidad de Extremadura
Publicación Tesis doctoral (DoctoralThesis)

Desarrollo y estudio del potencial inmunomodulador de tres novedosas estrategias para la aplicación de la terapia celular

  • Blázquez Durán, Rebeca
La terapia celular ha emergido en los últimos años como una nueva herramienta terapéutica para el tratamiento de diversas patologías. Sin embargo, la vía y tipo de administración de estas terapias son factores enormemente condicionantes para la correcta implantación del producto terapéutico y, por tanto, para su eficacia. En este sentido, es necesario el desarrollo de métodos y vías de administración alternativos que aseguren viabilidad y la correcta implantación de las células madre para conseguir la optimización de estas terapias. Esta tesis doctoral plantea estrategias alternativas para favorecer la implantación y aumentar el efecto terapéutico de las células madre adultas. Cada una de estas estrategias constituye un bloque con entidad propia que se desarrolla a lo largo de los diferentes apartados de este trabajo. La primera estrategia se centra en el uso combinado de las células madre mesenquimales (Mesenchymal Stem Cells, MSCs) con materiales quirúrgicos para favorecer la implantación y la actividad biológica de las células. La segunda estrategia aborda una nueva vía de administración en el contexto de la terapia celular para el tratamiento de lesiones de origen cardiovascular. En concreto, las células madre adultas son administradas por vía intrapericárdica, evaluando su biodistribución y actividad inmunomoduladora en un modelo de animal grande. Por último, para la tercera estrategia se evalúa la actividad inmunomoduladora de exosomas derivados de MSCs, y se realiza una comparativa de diferentes metodologías de aislamiento de dichas vesículas para su extrapolación y aplicación en el entorno clínico., In the recent years, stem cell therapy has emerged as a novel therapeutic tool for the treatment of a wide range of diseases. The administration route has a significant impact on the success of these therapies as it determines the correct implantation of the therapeutic product as well as its effectiveness. In this sense, the evaluation of new approaches, alternative implantation routes and techniques is urgently needed. This PhD work analyses different strategies to improve the implantation and the therapeutic effect of adult stem cells. The results of these strategies are discussed along the different sections of this thesis. The first strategy was focused in the combination of mesenchymal stem cells (Mesenchymal Stem Cells (MSCs) and surgical materials to enhance the implantation and biological activity of MSCs. The second strategy addresses an innovative administration route in the context of cardiovascular cell therapy. Concretely, adult stem cells were intrapericardially administered, evaluating their bio-distribution and immunomodulatory activity in a large animal model. Finally, the immunomodulatory activity of MSCs-derived exosomes was evaluated and different isolation methods were assessed for their extrapolation and application in the clinical context., Este trabajo ha sido financiado en parte por la Junta de Extremadura, el Fondo Social Europeo y los Fondos FEDER a través de las ayudas concedidas a Rebeca Blázquez (TE12066) y Javier García (TA13042 e IBI3123), así como por la ayuda a grupos catalogados de la Junta de Extremadura (GR15175), las ayudas de Redes temáticas de investigación cooperativa en salud (DR12/0042/0025 a Francisco Miguel Sánchez Margallo y Claudia Báez), el Séptimo Programa Marco Europeo (FP7-HEALTH-2009-1.4-3 242038) y por el centro de Cirugía de Mínima Invasión.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Hyphal Growth of Phagocytosed Fusarium oxysporum Causes Cell Lysis and Death of Murine Macrophages

  • Schäfer, Katja
  • Bain, Judith M.
  • Di Pietro, Antonio
  • Gow, Neil A. R.
  • Erwig, Lars P.
Fusarium oxysporum is an important plant pathogen and an opportunistic pathogen of humans. Here we investigated phagocytosis of F. oxysporum by J774.1 murine cell line macrophages using live cell video microscopy. Macrophages avidly migrated towards F. oxysporum germlings and were rapidly engulfed after cell-cell contact was established. F. oxysporum germlings continued hyphal growth after engulfment by macrophages, leading to associated macrophage lysis and escape. Macrophage killing depended on the multiplicity of infection. After engulfment, F. oxysporum inhibited macrophages from completing mitosis, resulting in large daughter cells fused together by means of a F. oxysporum hypha. These results shed new light on the initial stages of Fusarium infection and the innate immune response of the mammalian host.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Murine Model for Fusarium oxysporum Invasive Fusariosis Reveals Organ-Specific Structures for Dissemination and Long-Term Persistence

  • Schäfer, Katja
  • Di Pietro, Antonio
  • Gow, Neil A. R.
  • MacCallum, Donna
The soil-borne plant pathogen Fusarium oxysporum causes life-threatening invasive fusariosis in immunocompromised individuals. The mechanism of infection in mammalian hosts is largely unknown. In the present study we show that the symptoms of disseminated fusariosis caused by F. oxysporum in immunosuppressed mice are remarkably similar to those reported in humans. Distinct fungal structures were observed inside the host, depending on the infected organ. Invasive hyphae developed in the heart and kidney, causing massive colonization of the organs. By contrast, chlamydospore-like survival structures were found in lung, spleen and liver. Systemically infected mice also developed skin and eye infections, as well as thrombosis and necrosis in the tail. We further show that F. oxysporum can disseminate and persist in the organs of immunocompetent animals, and that these latent infections can lead to lethal systemic fusariosis if the host is later subjected to immunosuppressive treatment.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Giant vesicles: A powerful tool to reconstruct bacterial division assemblies in cell-like compartments

  • Jiménez, Mercedes
  • Martos, Ariadna
  • Raso, A.
  • Rivas, Germán
The use of artificial lipid membranes, structured as giant unilamellar vesicles (GUVs), provides the opportunity to investigate membrane-associated biological processes under defined experimental conditions. Due to their large size, they are uniquely adapted to investigate the properties and organization (in time and space) of macromolecular complexes incorporated in the vesicle interior by imaging and micro-spectroscopic techniques. Experimental methods to produce giant vesicles and to encapsulate proteins inside them are here reviewed. Previous experimental work to reconstitute elements of the bacterial division machinery in these membrane-like systems is summarized. Future challenges towards reconstructing minimal divisome assemblies in giant vesicles as cytomimetic containers are discussed. © 2013 Society for Applied Microbiology and John Wiley & Sons Ltd., This work was supported by the Spanish government through grants BIO2011-28941-C03-03, by the European Commission through contract HEALTH-F3-2009-223432, and by Human Frontiers Science Program through grant RGP0050/2010-C102, all of them to GR., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular dynamics analysis of conformational change of paramyxovirus F protein during the initial steps of membrane fusion

  • Martín-García, Fernando
  • Mendieta-Moreno, Jesús I.
  • Mendieta-Moreno, Jesús I.
  • Gómez-Puertas, Paulino
The fusion of paramyxovirus to the cell membrane is mediated by fusion protein (F protein) present in the virus envelope, which undergoes a dramatic conformational change during the process. Unlike hemagglutinin in orthomyxovirus, this change is not mediated by an alteration of environmental pH, and its cause remains unknown. Steered molecular dynamics analysis leads us to suggest that the conformational modification is mediated only by stretching mechanical forces once the transmembrane fusion peptide of the protein is anchored to the cell membrane. Such elongating forces will generate major secondary structure rearrangement in the heptad repeat A region of the F protein; from β-sheet conformation to an elongated coil and then spontaneously to an α-helix. In addition, it is proposed that the heptad repeat A region adopts a final three-helix coiled coil and that this structure appears after the formation of individual helices in each monomer. © 2012 Elsevier Inc., Spanish Ministerio de Ciencia e Innovación (SAF2007-61926, IPT2011-0964-900000 and SAF2011 13156-E); the Madrid regional authority through Grant S-BIO-0260/2006-COMBACT; and the European Commission through Grants FP7 HEALTH-F3-2009-223431 (EU Project ‘‘Divinocell’’) and FP7 HEALTH-2011-278603 (EU Project ‘‘Dorian); Fundación Ramón Areces, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mutations that hamper dimerization of foot-and-mouth disease virus 3A protein are detrimental for infectivity

  • González-Magaldi, Mónica
  • Postigo, Raúl
  • Vieira, Yuri A.
  • Rodríguez Pulido, Miguel Ramón
  • López-Viñas, Eduardo
  • Gómez-Puertas, Paulino
  • Rosas, María Flora
  • Sobrino Castelló, Francisco
Foot-and-mouth disease virus (FMDV) nonstructural protein 3A plays important roles in virus replication, virulence, and host range. In other picornaviruses, homodimerization of 3A has been shown to be relevant for its biological activity. In this work, FMDV 3A homodimerization was evidenced by an in situ protein fluorescent ligation assay. A molecular model of the FMDV 3A protein, derived from the nuclear magnetic resonance (NMR) structure of the poliovirus 3A protein, predicted a hydrophobic interface spanning residues 25 to 44 as the main determinant for 3A dimerization. Replacements L38E and L41E, involving charge acquisition at residues predicted to contribute to the hydrophobic interface, reduced the dimerization signal in the protein ligation assay and prevented the detection of dimer/multimer species in both transiently expressed 3A proteins and in synthetic peptides reproducing the N terminus of 3A. These replacements also led to production of infective viruses that replaced the acidic residues introduced (E) by nonpolar amino acids, indicating that preservation of the hydrophobic interface is essential for virus replication. Replacements that favored (Q44R) or impaired (Q44D) the polar interactions predicted between residues Q44 and D32 did not abolish dimer formation of transiently expressed 3A, indicating that these interactions are not critical for 3A dimerization. Nevertheless, while Q44R led to recovery of viruses that maintained the mutation, Q44D resulted in selection of infective viruses with substitution D44E with acidic charge but with structural features similar to those of the parental virus, suggesting that Q44 is involved in functions other than 3A dimerization. © 2012, American Society for Microbiology., Ministerio de Ciencia e Innovación (MICINN); Generalitat de Catalunya (SGR2009-0492); European Commission through grants FP7 HEALTH-F3-2009-223431 (EU project “Divinocell”) and FP7 HEALTH-2011-278603 (EU project “Dorian”); Fundación Ramón Areces; Centro de Computación Científica CCC-UAM, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Role of Gln(61) in HRas GTP Hydrolysis: A Quantum Mechanics/Molecular Mechanics Study

  • Martín-García, Fernando
  • Mendieta-Moreno, Jesús I.
  • López-Viñas, Eduardo
  • Gómez-Puertas, Paulino
  • Mendieta-Moreno, Jesús I.
Activation of the water molecule involved in GTP hydrolysis within the HRas RasGAP system is analyzed using a tailored approach based on hybrid quantum mechanics/molecular mechanics (QM/MM) simulation. A new path emerges: transfer of a proton from the attacking water molecule to a second water molecule, then a different proton is transferred from this second water molecule to the GTP. Gln 61 will stabilize the transient OH and H 3 O þ molecules thus generated. This newly proposed mechanism was generated by using, for the first time to our knowledge, the entire HRas-RasGAP protein complex in a QM/MM simulation context. It also offers a rational explanation for previous experimental results regarding the decrease of GTPase rate found in the HRas Q61A mutant and the increase exhibited by the HRas Q61E mutant., Ministerio de Ciencia e Innovación (SAF2007-61926); Madrid Regional Authority (S-BIO-0260/2006-COMBACT); European Commission (FP7 HEALTH-F3-2009-223431); European Social Fund, Fundación Ramón Areces, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pneumococcal phosphoglycerate kinase interacts with plasminogen and its tissue activator

  • Fulde, Marcus
  • Bernardo-García, Noelia
  • Rohde, Manfred
  • Nachtigall, Nadine
  • Frank, Ronald
  • Preissner, Klaus T.
  • Klett, Javier
  • Morreale, Antonio
  • Chhatwal, G. Singh
  • Hermoso, Juan A.
  • Bergmann, Simone
18 pags, 8 figs, 1 tab, Streptococcus pneumoniae is not only a commensal of the nasopharyngeal epithelium, but may also cause life-threatening diseases. Immune- electron microscopy studies revealed that the bacterial glycolytic enzyme, phosphoglycerate kinase (PGK), is localised on the pneumococcal surface of both capsulated and non-capsulated strains and colocalises with plasminogen. Since pneumococci may concentrate host plasminogen (PLG) together with its activators on the bacterial cell surface to facilitate the formation of plasmin, the involvement of PGK in this process was studied. Specific binding of human or murine PLG to strain-independent PGK was documented, and surface plasmon resonance analyses indicated a high affinity interaction with the kringle domains 1-4 of PLG. Crystal structure determination of pneumococcal PGK together with peptide array analysis revealed localisation of PLG-binding site in the N-terminal region and provided structural motifs for the interaction with PLG. Based on structural analysis data, a potential interaction of PGK with tissue plasminogen activator (tPA) was proposed and experimentally confirmed by binding studies, plasmin activity assays and thrombus degradation analyses. © Schattauer 2014., The research leading to these results has received funding from the European Community’s Seventh Framework Program under Grant Agreement no. HEALTH-F3–2009–223111. This work was also supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2011–25326) and Comunidad Autónoma de Madrid (CAM) S2010-BMD-2457 (BIPEDD2). J.K. is funded by a grant from Ministerio de Economía y Competitividad (BFU2011–24595). A.M. also acknowledges CAM for financial support to the Fundación Severo Ochoa through the AMAROUTO program
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Environmental and dietary determinants of metal exposure in four-year-old children from a cohort located in an industrial area (Asturias, Northern Spain)

  • Junqué, Eva
  • Tardón, Adonina
  • Fernandez-Somoano, Ana
  • Grimalt, Joan O.
Urine samples from four-year-old children located in a heavily industrialized zone in Asturias (Spain) were collected between 2009 and 2012 (n = 334). Vanadium (V; median 54 μg/g creatinine), cobalt (Co; 1.0 μg/g c.), nickel (Ni; 3.8 μg/g c.), copper (Cu; 22 μg/g c.), zinc (Zn; 590 μg/g c.), arsenic (As; 64 μg/g c.), selenium (Se; 49 μg/g c.), molybdenum (Mo; 110 μg/g c.), cadmium (Cd; 0.27 μg/g c.), antimony (Sb; 1.0 μg/g c.), cesium (Cs; 14 μg/g c.), barium (Ba; 2.6 μg/g c.), thallium (Tl; 0.55 μg/g c.) and lead (Pb; 1.9 μg/g c.) were analysed. Comparison with children from other sites showed that this Asturias cohort was characterized by high levels of V, As, Sb, Cs and Tl. The concentrations of Co, Ni, Zn, Cu, Mo, Se, Cd, Ba and Pb were within the range of other cohorts. Terrestrial dietary items were most strongly related to increased urinary concentrations of metals in children, e.g., red meat with Ba and Ni, pasta/cereal with Ni and Zn, sweets with Zn, Co, and Cu, eggs with Mo, Cd, and Cs, and dairy products with Co and Sb. Seafood was the second group of dietary items significantly related to increased metals, e.g., shellfish with Ba, Cs, Pb, and V, fatty fish with As, and lean fish with As and Se. In contrast, higher fruit intake was significantly associated with decreased Cu and Sb, and higher legume intake with decreased Cu, Se and Cs. Higher intakes of other dietary items also led to significant decreases in some metals, such as vegetables and lower concentrations of Se and Mo, and dairy products with decreases in Cu and As. These negative correlations implied very low concentrations of the mentioned metals in these foods. Higher exposure to traffic was associated with higher concentrations of Ba, present in brake components. Children living outside urban areas had higher concentrations of Se. No association of metals with smoking in the family was found., The authors would particularly like to thank all the participants for their generous collaboration and the staff from Hospital San Agustin in Aviles for their effort. This study was funded by grants from CIBERESP, FIS-FEDER (PI04/2018, PI09/02311, PI13/02429, PI18/00909), Obra Social Cajastur/Fundación Liberbank and Oviedo University. This paper was also supported by funding from the European Union projects: EDCMET (H2020-HEALTH/0490–825762) and PARC (HLTH-2021-ENVHLTH-3:101057014)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Inhibition of SARS-CoV-2 3CLpro by chemically modified tyrosinase from <i>Agaricus bisporus</i>

  • Aguilera-Rodriguez, David
  • Ortega-Alarcon, David
  • Vazquez-Calvo, Angela
  • Ricci, Veronica
  • Abian, Olga
  • Velazquez-Campoy, Adrian
  • Alcami, Antonio
  • Palomo, Jose M.
Antiviral compounds are crucial to controlling the SARS-CoV-2 pandemic. Approved drugs have been tested for their efficacy against COVID-19, and new pharmaceuticals are being developed as a complementary tool to vaccines. In this work, a cheap and fast purification method for natural tyrosinase from Agaricus bisporus (AbTyr) fresh mushrooms was developed to evaluate the potential of this enzyme as a therapeutic protein via the inhibition of SARS-CoV-2 3CLpro protease activity in vitro. AbTyr showed a mild inhibition of 3CLpro. Thus, different variants of this protein were synthesized through chemical modifications, covalently binding different tailor-made glycans and peptides to the amino terminal groups of the protein. These new tyrosinase conjugates were purified and characterized through circular dichroism and fluorescence spectroscopy analyses, and their stability was evaluated under different conditions. Subsequently, all these tyrosinase conjugates were tested for 3CLpro protease inhibition. From them, the conjugate between tyrosinase and a dextran-aspartic acid (6 kDa) polymer showed the highest inhibition, with an IC50 of 2.5 μg ml−1 and IC90 of 5 μg ml−1, with no cytotoxicity activity by polymer insertion. Finally, SARS-CoV-2 virus infection was studied. It was found that this new AbTyr-Dext6000 protein showed an 80% decrease in viral load. These results show the capacity of these tyrosinase bioconjugates as potential therapeutic proteins, opening the possibility of extension and applicability against other different viruses.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

eHealth Eurocampus: An innovative educational framework to train qualified professionals in the emerging ehealth sector

  • González Cid, Yolanda
  • Guerrero Tomé, Carlos
  • Lobo, Joao
  • Tarbal Roquero, Arian
  • Picking, Richard
  • Castell Ariño, Núria
  • Abdelaziz, Salih
  • Voegel, Bernd
  • Tous, Xisco
  • Pattichis, Constantinos
  • Rigaud, Bernard
The aim of this paper is to present the results of an initiative called the eHealth Eurocampus (http://ehealtheurocampus.eu), whose main goal is to define a framework to prepare professionals for the eHealth work environment. To do so, three main activities have been organized: develop eHealth learning materials, international intensive study programs for both health science and IT students and international training seminars for researches and professors. The eHealth Eurocampus project is an EU-funded Erasmus+ Strategic Partnership for higher education (September-2016 / August-2019) which aims at preparing qualified professionals able to cope with the challenge of “fostering a spirit of innovation in eHealth in Europe as the way forward to ensure better health and better and safer care for EU citizens, a more skilled workforce, more efficient and sustainable health and care systems, new business opportunities” (EC eHealth Action Plan 2012-2020). The consortium of the eHealth Eurocampus project along with the participants of the designed activities have created an original eHealth teaching-learning framework where university professors, students, researchers, and clinicians are able to share their experiences and knowledge with the aim of improving the skills of graduates in order to improve their employability. These are the organized activities and the topics that have been covered: - eHealth learning materials. Five courses of 6 ECTS each have been developed in the following topics: innovation and entrepreneurship, IT for a longer independent life, robotics for health care, graphics and medical imaging and eHealth applications and tools. - Intensive study programs. Three international summer schools for both health and IT students have been organized with an interdisciplinary approach. The first one deal with innovation and entrepreneurship in eHealth. The second one is focused on applications and tools for longer independent life. And robotics, graphics and medical imaging are covered in the third one. The summer schools have proven to be the best testbed for the learning materials and for innovative teaching methodologies in interdisciplinary context. - Training seminars. When you face the training of qualified eHealth professionals it is critical to have good educators. Two training seminars have been organized with the goal of share experiences and knowledge among practitioners, university teachers and researches of the health and IT fields. The topics covered in the seminars are eHealth Teaching Challenges and Accessibility, Inclusion, and Rehabilitation using IT, respectively. In this paper, we will introduce in detail the different activities carried out, the results and conclusions of this teaching-learning framework and how the different stakeholders would take advantage of it., Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

eHealth Eurocampus Project: preparing innovative ICT professionals

  • Castell Ariño, Núria
  • Lobo, Joao
  • Insa, Esther
  • Picking, Richard
  • González Cid, Yolanda
  • Abdelaziz, Salih
  • Voegel, Bernd
  • Tous, Xisco
  • Pattichis, Constantinos
  • Rigaud, Bernard
The eHealth Eurocampus project, an EU-funded project, aims at preparing innovative professionals able to cope with the challenge of fostering a spirit of innovation in eHealth in Europe as the way forward to ensure better health and better and safer care. The main objectives of the eHealth Eurocampus are improving the relevance and quality of higher education in the field of ICT applications for health, and fostering employability through curricula adaptation to labour market needs and the development of entrepreneurship skills. In the frame of this project we are developing course materials, and implementing new and innovative teaching methods that are tested through joint learning activities (summer schools), which will be used later on in different master courses. The project includes the organization of training seminars to exchange good practices and knowledge among teachers and researchers. The eHealth Eurocampus consortium includes 8 higher education institutions, a regional centre of technological development and entrepreneurship promotion, and a European Grouping of Territorial Cooperation. The partnership represents different European health management systems, from 5 European countries., Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Learning based on challenges in the context of multidisciplinary teamwork in ehealth: an evaluation of the students' experience

  • Graells, Ariadna
  • Castell Ariño, Núria
  • Insa, Esther
Education in eHealth is becoming of transcendental importance in the European social context. The progressive aging of the population has generated an increase in the prevalence of people with disabilities who demand more effective, adapted and flexible services. Advances in computer science and technology are enabling a qualitative leap in the care of these people, offering solutions to health demands. However, the incorporation of technology in the field of health requires the acquisition of new skills. The eHealth Eurocampus is an EU-funded Erasmus+ Strategic Partnership, whose primary aim is to support the development of innovative teaching materials and activities that will improve the relevance and quality of higher education in the field of eHealth. A total of 10 European institutions participate in the project, including universities, hospitals and technology companies. We present the results corresponding to the third edition of the summer school that took place in Barcelona during the month of July 2019. On this occasion, the main topic was the use of robotics and medical imaging for the treatment of physical and cognitive disability. A teaching methodology based on the presentation of challenges was used and for which the different groups had to work and give a technological solution. The challenges were proposed by real patients and healthcare professionals who, from their experience, presented a problem of their daily life: they went from issues related to the mobility of people with physical disabilities to the usability of medical devices in hospital settings. The students were organized in multi-disciplinary and multicultural teams, and they had to develop their prototypes to respond to the proposed challenge. The resulting projects were presented publicly to the patients and professionals themselves for further discussion. The results presented refer to the perceptions of participating students about the effectiveness of this methodology in the training of skills and competences for multidisciplinary work. In general, the adequacy of the methodology for the described objective is verified. Students highlight the importance of soft skills training in this type of context. Communication has appeared as the most important competence. Some students have mentioned that one of the great challenges encountered was to understand each other among the different backgrounds. However, they consider that the effort involved in having to reason their positions with understandable terms for all team members has improved their communication and conflict resolution skills. Another of the strengths that stand out in the results is the fact that the project was raised from real cases. However, the students identify as an aspect of improvement a greater interaction with the people who propose the challenges to validate the proposed solution during the development process of the project, and not only at the end. In conclusion, the results demonstrate the effectiveness of experiences of this type in the training of skills necessary for work in the context of digital health. It is important to incorporate initiatives of this type in the current university degrees for greater adaptation of training to the needs and demands of the social and professional context., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

  • Figlioli, Gisella
  • Catucci, Irene
  • Caleca, Laura
  • Lasheras, Sandra Viz
  • Pujol, Roser
  • Balmaña Gelpí, Judith
  • Diez Gibert, Orland
  • Bogliolo, Massimo
Càncer de mama; Genètica del càncer, Cáncer de mama; Genética del cáncer, Breast cancer; Cancer genetics, Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM -/- patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors., Peterlongo laboratory is supported by Associazione Italiana Ricerca sul Cancro (AIRC; IG2015 no.16732) to P. Peterlongo and by a fellowship from Fondazione Umberto Veronesi to G. Figlioli. Surrallés laboratory is supported by the ICREA-Academia program, the Spanish Ministry of Health (projects FANCOSTEM and FANCOLEN), the Spanish Ministry of Economy and Competiveness (projects CB06/07/0023 and RTI2018-098419-B-I00), the European Commission (EUROFANCOLEN project HEALTH-F5-2012-305421 and P-SPHERE COFUND project), the Fanconi Anemia Research Fund Inc, and the “Fondo Europeo de Desarrollo Regional, una manera de hacer Europa” (FEDER). CIBERER is an initiative of the Instituto de Salud Carlos III, Spain.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Factors influencing salivary lactate dehydrogenase levels in oral squamous cell carcinoma and oral potentially malignant disorders

  • López-Pintor Muñoz, Rosa María
  • González Serrano, José
  • Vallina, Carmen
  • Ivaylova Serkedzhieva, Katerina
  • Virto Ruiz, Leire
  • Nuevo, Paula
  • Caponio, Vito Carlo Alberto
  • Iniesta Albentosa, Margarita Isabel
  • Rodríguez Santamarta, Tania
  • Lequerica Fernández, Paloma
  • Iglesias Velázquez, Óscar
  • Hernández Vallejo, Gonzalo
  • de Vicente, Juan Carlos
Introduction: Salivary Lactate Dehydrogenase (sLDH) levels seem to be higher in patients with Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorders (OPMD) than a control group (CG). Methods: Case-control study. Patients with OPMD [oral leukoplakia (OL) and oral lichen planus (OLP)] and OSCC who attended two services in Spain were selected. sLDH in saliva was measured. Epidemiological, periodontal and specific variables related to OPMD and OSCC were collected. Results: A total of 92 patients were included: 12 with OSCC, 51 with OPMD (17 OL and 34 OLP), and 29 controls. sLDH values were higher in the OSCC, followed by the OPMD and CG groups, although no significant differences were observed. In the OSCC group, larger tumor size was associated with higher sLDH levels. In the OLP group, sLDH values were higher in patients with symptomatic lesions than in patients with only white lesions, but not significantly. No associations were observed between sLDH and the type of OL (homogeneous vs. non-homogeneous) and the degree of dysplasia. When analyzing periodontal variables among OSCC, OPMD and CG, periodontal probing depth (PPD) and bleeding on probing were significantly higher in the OSCC group, while the plaque index was higher in OPMD patients. The linear regression model for sLDH in the total group identified age and PPD as significant predictors of sLDH levels. Discussion: Although sLDH values were higher in OSCC and OPMD patients than in a CG, the results do not support the use of sLDH as a reliable prognostic biomarker of malignancy. Future studies need to consider other factors that may influence sLDH levels, such as age and periodontal status.
Archivo Digital UPM
Publicación Contribución de congreso (ConferenceOutput)

Liquid crystal biosensing of microorganisms

  • Otón Sánchez, José Manuel|||0000-0001-8070-9180
  • Otón Martínez, Eva
  • Quintana Arregui, Patxi Xabier|||0000-0003-4315-2701
  • Geday, Morten Andreas|||0000-0002-5625-1162
Archivo Digital UPM
Publicación Contribución de congreso (ConferenceOutput)

Detection of microbes using flowing lyotropic liquid crystals

  • Geday, Morten Andreas|||0000-0002-5625-1162
  • Caño García, Manuel|||0000-0002-4437-4296
  • Escolano, José Miguel
  • Otón Martínez, Eva
  • Otón Sánchez, José Manuel|||0000-0001-8070-9180
  • Quintana, Xavier
Archivo Digital UPM
Publicación Artículo científico (JournalArticle)

Rapid detection of pathogens using lyotropic liquid crystals

  • Otón Martínez, Eva
  • Otón Sánchez, José Manuel|||0000-0001-8070-9180
  • Caño García, Manuel|||0000-0002-4437-4296
  • Escolano Moyano, José Miguel
  • Quintana Arregui, Patxi Xabier|||0000-0003-4315-2701
  • Geday, Morten Andreas|||0000-0002-5625-1162
Archivo Digital UPM
Publicación Libro o Monografía (Book)

Sustainability, Urban Design and Health Multidisciplinary expert panels improving Urban Health trainings for technicians and trainers. Delphi´s pannel experts evaluation

  • Pozo Menéndez, Elisa
  • Lamíquiz Daudén, Francisco José|||0000-0003-4725-8829
  • Higueras García, Esther|||0000-0002-0182-8884
Archivo Digital UPM
Publicación Artículo científico (JournalArticle)

Influence of Liquid Properties on the Performance of S0-mode Lamb Wave Sensors: A Theoretical Analysis

Archivo Digital UPM
Publicación Artículo científico (JournalArticle)

Growth of carbon nanotube forests on metallic thin films

  • Olivares Roza, Jimena|||0000-0003-4396-4363
  • Mirea, Teona|||0000-0003-2324-4895
  • Díaz Durán, Bárbara
  • Clement Lorenzo, Marta|||0000-0003-4956-8206
  • Miguel Ramos, Mario de
  • Sangrador García, Jesús|||0000-0001-9582-8692
  • Frutos Vaquerizo, José de|||0000-0003-1582-9447
  • Iborra Grau, Enrique|||0000-0002-1385-1379
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Exploring the mediation of dna methylation across the epigenome between childhood adversity and first episode of psychosis—findings from the EU-GEI study

  • Alameda, L.
  • Liu, Z.
  • Sham, P. C.
  • Bobes, Julio|||0000-0003-2187-4033
The EU-GEI Project is funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI); Craig Morgan is part funded by the ESRC (ESRC Centre for Society and Mental Health at King’s College London: ESRC Reference: ES/S012567/1), and the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London., Alameda L., Liu Z., Sham P.C., Aas M., Trotta G., Rodriguez V., Di Forti M., Stilo S.A., Kandaswamy R., Arango C., Arrojo M., Bernardo M., Bobes J., de Haan L., Del-Ben C.M., Gayer-Anderson C., Sideli L., Jones P.B., Jongsma H.E., Kirkbride J.B., La Cascia C., Lasalvia A., Tosato S., Llorca P.-M., Menezes P.R., van Os J., Quattrone D., Rutten B.P., Santos J.L., Sanjuán J., Selten J.-P., Szöke A., Tarricone I., Tortelli A., Velthorst E., Morgan C., Dempster E., Hannon E., Burrage J., Dwir D., Arumuham A., Mill J., Murray R.M., Wong C.C.Y.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

White noise speech illusions: A trait-dependent risk marker for psychotic disorder?

  • Schepers, Elaine
  • Lousberg, Richel
  • Guloksuz, Sinan
  • Bobes, Julio|||0000-0003-2187-4033
  • Saiz Martínez, Pilar Alejandra
  • García-Portilla González, María Paz|||0000-0003-3643-1622
Supported by the European Community’s Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI), Schepers, E., Lousberg, R., Guloksuz, S., Pries, L.-K., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D., Richards, A.L., Akdede, B., Binbay, T., Altınyazar, V., Yalınçetin, B., Gümüş-Akay, G., Cihan, B., Soygür, H., Ulaş, H., Cankurtaran, E.Ş., Kaymak, S.U., Mihaljevic, M.M., Petrovic, S.A., Mirjanic, T., Bernardo, M., Cabrera, B., Bobes, J., Saiz, P.A., García-Portilla, M.P., Sanjuan, J., Aguilar, E.J., Santos, J.L., Jiménez-López, E., Arrojo, M., Carracedo, A., López, G., González-Peñas, J., Parellada, M., Maric, N.P., Atbaşoğlu, C., Ucok, A., Alptekin, K., Saka, M.C., Arango, C., Rutten, B.P.F., van Os, J.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

A replication study of JTC bias, genetic liability for psychosis and delusional ideation

  • Henquet C.
  • Van Os J.
  • Pries L.K.
  • Bobes, Julio|||0000-0003-2187-4033
  • Saiz Martínez, Pilar Alejandra
  • García-Portilla González, María Paz|||0000-0003-3643-1622
The EUGEI project was supported by the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). Dr O'Donovan is supported by MRC programme grant (G08005009) and an MRC Centre grant (MR/L010305/1), Henquet, C., Van Os, J., Pries, L.K., Rauschenberg, C., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D., Richards, A.L., Akdede, B., Binbay, T., Altlnyazar, V., Yallnçetin, B., Gümüş-Akay, G., Cihan, B., Soygür, H., Ulaş, H., Cankurtaran, E.S., Kaymak, S.U., Mihaljevic, M.M., Petrovic, S.S., Mirjanic, T., Bernardo, M., Mezquida, G., Amoretti, S., Bobes, J., Saiz, P.A., Garciá-Portilla, M.P., Sanjuan, J., Aguilar, E.J., Santos, J.L., Jiménez-López, E., Arrojo, M., Carracedo, A., López, G., González-Penãs, J., Parellada, M., Maric, N.P., Atbaşoelu, C., Ucok, A., Alptekin, K., Saka, M.C., Arango, C., O'Donovan, M., Rutten, B.P.F., Gülöksüz, S.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Examining facial emotion recognition as an intermediate phenotype for psychosis: findings from the EUGEI study

  • Fusar Poli, L.
  • Pries, L. K.
  • Van Os, J.
  • Bobes, Julio|||0000-0003-2187-4033
  • Saiz Martínez, Pilar Alejandra
  • García-Portilla González, María Paz|||0000-0003-3643-1622
The EUGEI project was supported by the European Community’s Seventh Framework Program under grant agreement No. HEALTH-F2- 2009-241909 (Project EU-GEI). Dr. Arango was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16-PE07CP1, PI16/02012, PI19/024); CIBERSAM (...), Fusar-Poli, L; Pries, LK; van Os, J; Erzin, G; Delespaul, P; Kenis, G; Luykx, JJ; Lin, BCD; Richards, AL; Akdede, B; Binbay, T; Altinyazar, V; Yalincetin, B; Gumus-Akay, G; Cihan, B; Soygur, H; Ulas, H; Cankurtaran, ES; Kaymak, SU; Mihaljevic, MM; Andric-Petrovic, S; Mirjanic, T; Bernardo, M; Mezquida, G; Amoretti, S; Bobes, J; Saiz, PA; Garcia-Portilla, MP; Sanjuan, J; Aguilar, EJ; Santos, JL; Jimenez-Lopez, E; Arrojo, M; Carracedo, A; Lopez, G; Gonzalez-Penas, J; Parellada, M; Maric, NP; Atbasoglu, C; Ucok, A; Alptekin, K; Saka, MC; Aguglia, E; Arango, C; O'Donovan, M; Rutten, BPF; Guloksuz, S
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: the EU-GEI study

  • Aas, M.
  • Alameda, L.
  • Di Forti, M.
  • Bobes, Julio|||0000-0003-2187-4033
The European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) Project is funded by grant agreement HEALTH-F2-2010-241909 (Project EU-GEI) from the European Community’s Seventh Framework Programme., Aas, M; Alameda, L; Di Forti, M; Quattrone, D; Dazzan, P; Trotta, A; Ferraro, L; Rodriguez, V; Vassos, E; Sham, P; Tripoli, G; La Cascia, C; La Barbera, D; Tarricone, I; Muratori, R; Berardi, D; Lasalvia, A; Tosato, S; Szoke, A; Llorca, PM; Arango, C; Tortelli, A; de Haan, L; Velthorst, E; Bobes, J; Bernardo, M; Sanjuan, J; Santos, JL; Arrojo, M; Del-Ben, CM; Menezes, PR; Selten, JP; Jones, PB; Jongsma, HE; Kirkbride, JB; Rutten, BPF; van Os, J; Gayer-Anderson, C; Murray, RM; Morgan, C
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum

  • Pries, L. K.
  • Dal Ferro, G. A.
  • Bobes, Julio|||0000-0003-2187-4033
  • Saiz Martínez, Pilar Alejandra
  • García-Portilla González, María Paz|||0000-0003-3643-1622
The EUGEI project was supported by the European Community’s Seventh Framework Program under grant agreement no. HEALTH-F2-2009-241909 (Project EU-GEI). Dr O’Donovan is supported by MRC programme grant (G08005009) and an MRC Centre grant (MR/ L010305/1). Dr Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation. Drs Guloksuz and van Os are supported by the Ophelia research project, ZonMw grant number: 636340001. Dr Arango was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024); CIBERSAM; Madrid Regional Government (B2017/BMD-3740, AGES-CM-2); Fundación Familia Alonso and Fundación Alicia Koplowitz., Pries, L.-K., Dal Ferro, G.A., Van Os, J., Delespaul, P., Kenis, G., Lin, B.D., Luykx, J.J., Richards, A.L., Akdede, B., Binbay, T., Altlnyazar, V., Yallnçetin, B., Gümüş-Akay, G., Cihan, B., Soygür, H., Ulaş, H., Åžahin Cankurtaran, E., Ulusoy Kaymak, S., Mihaljevic, M.M., Andric Petrovic, S., Mirjanic, T., Bernardo, M., Mezquida, G., Amoretti, S., Bobes, J., Saiz, P.A., Garciá-Portilla, M.P., Sanjuan, J., Aguilar, E.J., Santos, J.L., Jiménez-López, E., Arrojo, M., Carracedo, A., López, G., González-Penãs, J., Parellada, M., Maric, N.P., AtbaşoÄalu, C., Ucok, A., Alptekin, K., Can Saka, M., Arango, C., O'Donovan, M., Tosato, S., Rutten, B.P.F., Guloksuz, S., and Genetic Risk and Outcome of Psychosis (GROUP) investigators
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Suicide prevention for youth - a mental health awareness program: lessons learned from the Saving and Empowering Young Lives in Europe (SEYLE) intervention study

  • Wasserman, Camilla
  • Hoven, Christina W.
  • Wasserman, Danuta
  • Al-Halabí Díaz, Susana|||0000-0003-1162-2115
  • Bobes, Julio|||0000-0003-2187-4033
The SEYLE project is supported by the European Union through the Seventh Framework Program (FP7), Grant agreement number HEALTH-F2-2009-223091., Wasserman, C., Hoven, C.W., Wasserman, D., Carli, V., Sarchiapone, M., Al-Halabí, S., Apter, A., Balazs, J., Bobes, J., Cosman, D., Farkas, L., Feldman, D., Fischer, G., Graber, N., Haring, C., Herta, D.C., Iosue, M., Kahn, J.-P., Keeley, H., Klug, K., McCarthy, J., Tubiana-Potiez, A., Varnik, A., Varnik, P., Žiberna, J., Poštuvan, V.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the multi-center EU-GEI study

  • Ajnakina, O.
  • Rodríguez, V.
  • Quattrone, D.
  • Bobes, Julio|||0000-0003-2187-4033
  • EU-GEI WP2
The EU-GEI Project is funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010–241909 (Project EU-GEI)., Ajnakina, O., Rodriguez, V., Quattrone, D., Di Forti, M., Vassos, E., Arango, C., Berardi, D., Bernardo, M., Bobes, J., De Haan, L., Del-Ben, C.M., Gayer-Anderson, C., Jongsma, H.E., Lasalvia, A., Tosato, S., Llorca, P.-M., Menezes, P.R., Rutten, B.P., Santos, J.L., Sanjuán, J., Selten, J.-P., Szöke, A., Tarricone, I., D'andrea, G., Richards, A., Tortelli, A., Velthorst, E., Jones, P.B., Arrojo Romero, M., La Cascia, C., Kirkbride, J.B., Van Os, J., O'donovan, M., Murray, R.M., EU-GEI WP2 Group
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study

  • Quattrone, D.
  • Ferraro, L.
  • Tripoli, G.
  • La Cascia, C.
  • Quigley, H.
  • Quattrone, A.
  • Jongsma, H. E.
  • Del Peschio, S.
  • Gatto, G.
  • Gayer Anderson, C.
  • Jones, P. B.
  • Kirkbride, J. B.
  • La Barbera, D.
  • Tarricone, I.
  • Berardi, D.
  • Tosato, S.
  • Lasalvia, A.
  • Szöke, A.
  • Arango, C.
  • Bernardo, M.
  • Bobes, Julio|||0000-0003-2187-4033
The work was supported by: Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust to DQ; DFG Heisenberg professorship (no. 389624707) to UR. National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI). The Brazilian study was funded by the São Paulo Research Foundation under grant number 2012/0417-0., Quattrone, D., Ferraro, L., Tripoli, G., La Cascia, C., Quigley, H., Quattrone, A., Jongsma, H.E., Del Peschio, S., Gatto, G., Gayer-Anderson, C., Jones, P.B., Kirkbride, J.B., La Barbera, D., Tarricone, I., Berardi, D., Tosato, S., Lasalvia, A., Szöke, A., Arango, C., Bernardo, M., Bobes, J., Del Ben, C.M., Menezes, P.R., Llorca, P.-M., Santos, J.L., Sanjuán, J., Tortelli, A., Velthorst, E., De Haan, L., Rutten, B.P.F., Lynskey, M.T., Freeman, T.P., Sham, P.C., Cardno, A.G., Vassos, E., Van Os, J., Morgan, C., Reininghaus, U., Lewis, C.M., Murray, R.M., Di Forti, M.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

The impact of school-based screening on service use in adolescents at risk for mental health problems and risk-behaviour

  • Lustig, S.
  • Kaess, M.
  • Schnyder, N.
  • Bobes, Julio|||0000-0003-2187-4033
  • Saiz Martínez, Pilar Alejandra
European Union, FP7 [HEALTH-F2-2009-223091]; Projekt DEAL, Lustig S, Kaess M, Schnyder N, Michel C, Brunner R, Tubiana A, Kahn JP, Sarchiapone M, Hoven CW, Barzilay S, Apter A, Balazs J, Bobes J, Saiz PA, Cozman D, Cotter P, Kereszteny A, Podlogar T, Postuvan V, Värnik A, Resch F, Carli V, Wasserman D
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Correlates of sexual initiation among European adolescents

  • Gambadauro, Pietro
  • Carli, Vladimir
  • Hadlaczky, Gergö
  • Bobes, Julio|||0000-0003-2187-4033
The SEYLE project was funded by the European Union Seventh Framework Program (FP7; HEALTH-F2-2009-223091). Judit Balazs was supported by the Ja´nos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Gambadauro, P., Carli, V., Hadlaczky, G., Sarchiapone, M., Apter, A., Balazs, J., Banzer, R., Bobes, J., Brunner, R., Cosman, D., Farkas, L., Haring, C., Hoven, C.W., Kaess, M., Kahn, J.P., McMahon, E., Postuvan, V., Sisask, M., Värnik, A., Sedivy, N.Z., Wasserman, D.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Excessive and pathological internet use - risk-behavior or psychopathology?

  • Kaess, Michael
  • Klar, Johanna
  • Kindler, Jochen
  • Bobes, Julio|||0000-0003-2187-4033
  • Saiz Martínez, Pilar Alejandra
Coordination Theme 1 (Health) of the European Union Seventh Framework Program (FP7) [HEALTH-F2-2009-223091], Kaess, M., Klar, J., Kindler, J., Parzer, P., Brunner, R., Carli, V., Sarchiapone, M., Hoven, C.W., Apter, A., Balazs, J., Barzilay, S., Bobes, J., Cozman, D., Gomboc, V., Haring, C., Kahn, J.-P., Keeley, H., Meszaros, G., Musa, G.J., Postuvan, V., Saiz, P., Sisask, M., Varnik, P., Resch, F., Wasserman, D.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

  • Pries, Lotta Katrin
  • Lage-Castellanos, Agustin
  • Delespaul, Philippe
  • Petrovic, S. A.
  • Mirjanic, T.
  • Bobes, Julio|||0000-0003-2187-4033
  • Saiz Martínez, Pilar Alejandra
  • García-Portilla González, María Paz|||0000-0003-3643-1622
  • Genetic Risk and Outcome of Psychosis (GROUP) investigators
The EUGEI project was supported by the grant agreement HEALTH-F2-2010-241909 from the European Community’s Seventh Framework Programme. The authors are grateful to the patients and their families for participating in the project. They also thank all research personnel involved in the GROUP project, in particular J. van Baaren, E. Veermans, G. Driessen, T. Driesen, E. van’t Hag and J. de Nijs. Bart PF Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation., Pries, L.-K., Lage-Castellanos, A., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D., Richards, A.L., Akdede, B., Binbay, T., Altinyazar, V., Yalinçetin, B., Gümüş-Akay, G., Cihan, B., Soygür, H., Ulaş, H., Cankurtaran, E.Ş., Kaymak, S.U., Mihaljevic, M.M., Petrovic, S.A., Mirjanic, T., Bernardo, M., Cabrera, B., Bobes, J., Saiz, P.A., García-Portilla, M.P., Sanjuan, J., Aguilar, E.J., Santos, J.L., Jiménez-López, E., Arrojo, M., Carracedo, A., López, G., González-Peñas, J., Parellada, M., Maric, N.P., Atbaşoğlu, C., Ucok, A., Alptekin, K., Saka, M.C., Arango, C., O'Donovan, M., Rutten, B.P.F., van Os, J., Guloksuz, S.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

  • Figlioli, Gisella
  • Catucci, Irene
  • Caleca, Laura
  • Lasheras, Sandra Viz
  • Pujol, Roser
  • Balmaña Gelpí, Judith
  • Diez Gibert, Orland
  • Bogliolo, Massimo
Càncer de mama; Genètica del càncer, Cáncer de mama; Genética del cáncer, Breast cancer; Cancer genetics, Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM -/- patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors., Peterlongo laboratory is supported by Associazione Italiana Ricerca sul Cancro (AIRC; IG2015 no.16732) to P. Peterlongo and by a fellowship from Fondazione Umberto Veronesi to G. Figlioli. Surrallés laboratory is supported by the ICREA-Academia program, the Spanish Ministry of Health (projects FANCOSTEM and FANCOLEN), the Spanish Ministry of Economy and Competiveness (projects CB06/07/0023 and RTI2018-098419-B-I00), the European Commission (EUROFANCOLEN project HEALTH-F5-2012-305421 and P-SPHERE COFUND project), the Fanconi Anemia Research Fund Inc, and the “Fondo Europeo de Desarrollo Regional, una manera de hacer Europa” (FEDER). CIBERER is an initiative of the Instituto de Salud Carlos III, Spain.